LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $376,920 | +11.5% | 5,604 | +14.6% | 0.00% | – |
| Q2 2023 | $338,070 | +43.5% | 4,892 | 0.0% | 0.00% | – |
| Q1 2023 | $235,661 | +60.3% | 4,892 | +65.8% | 0.00% | – |
| Q4 2022 | $146,969 | +21.5% | 2,951 | 0.0% | 0.00% | – |
| Q3 2022 | $121,000 | +33.0% | 2,951 | +78.5% | 0.00% | – |
| Q2 2022 | $91,000 | -7.1% | 1,653 | -38.9% | 0.00% | – |
| Q1 2022 | $98,000 | -22.2% | 2,705 | 0.0% | 0.00% | – |
| Q4 2021 | $126,000 | +4100.0% | 2,705 | +3937.3% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | +50.0% | 67 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 67 | +1.5% | 0.00% | – |
| Q3 2020 | $2,000 | -94.6% | 66 | -92.4% | 0.00% | – |
| Q2 2020 | $37,000 | – | 865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |